Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes

Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes

BackgroundImmunoglobulin A nephropathy (IgAN) is a highly prevalent glomerular disease. The diagnosis potential of the gut microbiome in IgAN has not been fully evaluated. Gut microbiota, serum metabolites, and clinical phenotype help to further deepen the understanding of IgAN.Patients and methodsC...

Full description

Bibliographic Details
Main Authors:	Yijun Dong, Jiaojiao Chen, Yiding Zhang, Zhihui Wang, Jin Shang, Zhanzheng Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	glomerulonephritis IgA chronic kidney disease gut microbiome non‐invasive diagnostic tools metabolic networks
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.1059692/full

Similar Items

Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation
by: Gabriella Moroni, et al.
Published: (2019-06-01)

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study
by: Ting Wang, et al.
Published: (2022-07-01)

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients
by: Ge Yan, et al.
Published: (2022-11-01)

Recurrent Immunoglobulin A Nephropathy after Kidney Transplant—An Updated Review
by: Hwarang S. Han, et al.
Published: (2023-09-01)

Diagnostic value of α1-MG and URBP in early diabetic renal impairment
by: Yukun Zhou, et al.
Published: (2023-10-01)

IgA Nephropathy in Salvador, Brazil. Clinical and laboratory presentation at diagnosis
by: Brenda Navarro de Souza, et al.
Published: (2018-05-01)

Gut Microbes in Immunoglobulin A Nephropathy and Their Potential Therapeutic Applications
by: Yi Wang, et al.
Published: (2022-05-01)

The transcription factor HMGB2 indirectly regulates APRIL expression and Gd-IgA1 production in patients with IgA nephropathy
by: Huijuan Tian, et al.
Published: (2024-12-01)

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
by: Wei Yu, et al.
Published: (2022-08-01)

Kartagener syndrome complicated by immunoglobulin A nephropathy
by: Oka K, et al.
Published: (2018-12-01)

The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy
by: Wei Yu, et al.
Published: (2020-01-01)

Characterization and diagnostic value of the gut microbial composition in patients with minimal change disease
by: Yiding Zhang, et al.
Published: (2022-12-01)

Nefropatia por IgA nas espondiloartrites IgA nephropathy in spondyloarthritis
by: Daniela Castelo Azevedo, et al.
Published: (2011-02-01)

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
by: Peipei Wang, et al.
Published: (2022-12-01)

Nefropatia por IgA em portadores de espondiloartrites acompanhados no Serviço de Reumatologia do Hospital das Clínicas da UFMG IgA nephropathy in patients with spondyloarthritis followed-up at the Rheumatology Service of Hospital das Clínicas/UFMG
by: Daniela Castelo Azevedo, et al.
Published: (2011-10-01)

Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli
by: Flavia Teodora Ioana Paunas, et al.
Published: (2019-11-01)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)

Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy
by: Jin Shang, et al.
Published: (2022-10-01)

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
by: Le Weibo, et al.
Published: (2012-11-01)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01)

Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective
by: Agni Nhirmal Kumar Sugurmar, et al.
Published: (2021-04-01)

Infection-related immunoglobulin A nephropathy or IgA-dominant postinfectious glomerulonephritis; what is in a name?
by: Ghazal Ghasempoor Dabaghi, et al.
Published: (2021-07-01)

Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies
by: Shisheng Han, et al.
Published: (2022-05-01)

Minimal change disease versus IgA nephropathy
by: Jabur Wael
Published: (2009-01-01)

Interactions between the Gut Microbiome and Mucosal Immunoglobulins A, M, and G in the Developing Infant Gut
by: Anders Janzon, et al.
Published: (2019-12-01)

MicroRNAs in IgA nephropathy
by: Xingchen Yao, et al.
Published: (2021-01-01)

Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers
by: Amir Taherkhani, et al.
Published: (2019-12-01)

The Human Virome and Its Crosslink with Glomerulonephritis and IgA Nephropathy
by: Fabio Sallustio, et al.
Published: (2023-02-01)

Primary IgA nephropathy: current challenges and future prospects
by: Penfold RS, et al.
Published: (2018-04-01)

Cyclosporine therapy could be considered for membranoproliferative glomerulonephritis with immunoglobulin A deposits: a case report
by: Yuko Hidaka, et al.
Published: (2022-11-01)

Aberrant Blood Vessel Formation Connecting the Glomerular Capillary Tuft and the Interstitium Is a Characteristic Feature of Focal Segmental Glomerulosclerosis-like IgA Nephropathy
by: Beom Jin Lim, et al.
Published: (2016-05-01)

Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy
by: Frederick W.K. Tam, et al.
Published: (2023-12-01)

Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation
by: Mayuko Kawabe, et al.
Published: (2020-09-01)

Study on the Mechanism of Budesonide in the Treatment of IgA Nephropathy Based on Network Pharmacology
by: ZHANG Kang, ZHAO Tingting, ZHANG Bo, GAO Mengqi, LI Yuxi, WANG Shaopeng, ZHAO Wenjing
Published: (2023-12-01)

The influence of environmental factors on clinical pathological changes of patients with immunoglobulin A nephropathy from different areas of China
by: Ping Fan, et al.
Published: (2018-10-01)

The Association between Serum Hemoglobin and Renal Prognosis of IgA Nephropathy
by: Tae Ryom Oh, et al.
Published: (2021-01-01)

Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry–publication on behalf of Taiwan Society of Nephrology
by: Hsien-Fu Chiu, et al.
Published: (2018-01-01)

Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy
by: Gyl Eanes Barros Silva, et al.
Published: (2012-07-01)

The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China
by: Lu Huan, et al.
Published: (2016-05-01)

Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report
by: Tadasu Kojima, et al.
Published: (2019-01-01)